[Systemic therapy for hepatocellular carcinoma: from molecular targeted agent to combined immunotherapy]
Nihon Shokakibyo Gakkai Zasshi
.
2023;120(1):46-55.
doi: 10.11405/nisshoshi.120.46.
[Article in Japanese]
Authors
Masafumi Ikeda
1
,
Hiroshi Imaoka
1
,
Shuichi Mitsunaga
1
Affiliation
1
Department of Hepatobiliary & Pancreatic Oncology, National Cancer Center Hospital East.
PMID:
36631115
DOI:
10.11405/nisshoshi.120.46
No abstract available
MeSH terms
Antineoplastic Agents* / therapeutic use
Carcinoma, Hepatocellular* / drug therapy
Combined Modality Therapy
Humans
Immunotherapy
Liver Neoplasms* / drug therapy
Molecular Targeted Therapy
Substances
Antineoplastic Agents